Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 8/2009

01-10-2009 | Letter to the Editor

Comment on: Lacasse Y, Martin S, Gagne D, Lakhal L (2009) Dose–response meta-analysis of silica and lung cancer. Cancer Causes Control (e-published ahead of print) doi:10.1007/s10552-009-9296-0

Author: Peter Morfeld

Published in: Cancer Causes & Control | Issue 8/2009

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Lacasse Y, Martin S, Gagne D, Lakhal L (2009) Dose–response meta-analysis of silica and lung cancer. Cancer Causes Control (e-published ahead of print). doi:10.​1007/​s10552-009-9296-0
2.
Checkoway H, Heyer NJ, Seixas NS et al (1997) Dose–response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry. Am J Epidemiol 145:680–688PubMed
3.
Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia
Metadata
Title
Comment on: Lacasse Y, Martin S, Gagne D, Lakhal L (2009) Dose–response meta-analysis of silica and lung cancer. Cancer Causes Control (e-published ahead of print) doi:10.1007/s10552-009-9296-0
Author
Peter Morfeld
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 8/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9360-9

Other articles of this Issue 8/2009

Cancer Causes & Control 8/2009 Go to the issue

Original paper

Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California

Original paper

Association of metabolic syndrome with insulin-like growth factors among adults in the US

Original paper

Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors

Brief report

Family cancer history affecting risk of colorectal cancer in a prospective cohort of Chinese women

Original paper

Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women—implications for vaccination

OriginalPaper

Adiposity in relation to colorectal adenomas and hyperplastic polyps in women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits